Rev Esp Quimioter 2022;35(Suppl.3):54-62

COVID-19 in donation and transplant

FRANCISCO JAVIER CANDEL, CÁNDIDO PARDO REY, JUAN IGNACIO TORRES-GONZÁLEZ, PAULA FERNÁNDEZ-VEGA, MARCOS FRAGIEL, DAVID OTEO, ENRIQUE DEL TORO, MÓNICA VEGA-BAYOL, CRISTINA OUTON, MARTA ENCABO, AGUSTÍN GARCÍA-MARUGÁN, SARA RESINO, DOLORES PARRA, MAYRA MATESANZ, FRANCISCO J. DEL RIO GALLEGOS

Published: 24 October 2022

http://www.doi.org/10.37201/req/s03.13.2022

SARS-CoV-2 infection has had a major impact on donation and transplantation. Since the cessation of activity two
years ago, the international medical community has rapidly generated evidence capable of sustaining and increasing this neccesary activity. This paper analyses the epidemiology and burden of COVID-19 in donation and transplantation, the pathogenesis of the infection and its relationship with graft-mediated transmission, the impact of vaccination on donation and transplantation, the evolution of donation in Spain throughout the pandemic, some lessons learned in SARS-CoV-2 infected donor recipients with positive PCR and the applicability of the main therapeutic tools recently approved for treatment among transplant recipients.

Rev Esp Quimioter 2022; 35(Suppl.3):54-62 [Full-text PDF]